MAIA Biotechnology, Inc. (MAIA)
USD 1.94
(-11.82%)
USD 1.94
(-11.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -13.07 Million | -11.65 Million | -4.12 Million | -1.84 Million | -1.56 Million |
| Net Income | -19.77 Million | -15.76 Million | -12.57 Million | -6.95 Million | -6.49 Million |
| Depreciation & Amortization | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 3.08 Million | 2.31 Million | 2.72 Million | 3.88 Million | 4.13 Million |
| Change in working capital | 3.08 Million | 793.16 Thousand | 1.12 Million | 1.25 Million | 269.45 Thousand |
| Other non-cash items | 2.98 Million | 1 Million | 4.6 Million | -28.02 Thousand | 4.55 Million |
| Investing Cash Flow | - | - | - | - | 187.55 Thousand |
| Investments in PPE | -4.00 | - | - | - | - |
| Acquisitions | - | - | - | - | 187.55 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 187.55 Thousand |
| Financing Cash Flow | 9.27 Million | 12.47 Million | 14.03 Million | 798.05 Thousand | 2.22 Million |
| Debt repayment | - | - | -367.00 | -3633.00 | -10 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -58.21 Thousand | - |
| Common Stock Issuance | 5.75 Million | 12.03 Million | 5.74 Million | 50 Thousand | 2.08 Million |
| Other Financing Activities | 9.27 Million | 12.47 Million | 8.29 Million | 868.11 Thousand | 125 Thousand |
| Accounts receivables | 158.4 Thousand | -269.39 Thousand | - | - | - |
| Accounts payables | 471.89 Thousand | 211.34 Thousand | 805.51 Thousand | -2304.00 | 104.82 Thousand |
| Inventory | - | 269.39 Thousand | - | - | - |
| Other working capital | 2.45 Million | 581.81 Thousand | 320.23 Thousand | 1.25 Million | 164.63 Thousand |
| Cash at beginning of period | 10.95 Million | 10.57 Million | 663.45 Thousand | 1.7 Million | 1.7 Million |
| Cash at end of period | 7.15 Million | 10.95 Million | 10.57 Million | 663.45 Thousand | 1.7 Million |
| Capital Expenditure | -4.00 | - | - | - | - |
| Effect of forex changes on cash | -117.00 | -4430.00 | - | - | -843.03 Thousand |
| Net cash flow / Change in cash | -3.8 Million | 376.63 Thousand | 9.91 Million | -1.04 Million | 1710.00 |
| Free Cash Flow | -13.07 Million | -11.65 Million | -4.12 Million | -1.84 Million | -1.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.87 Million | -8.06 Million | -6.25 Million | -19.77 Million | -4.87 Million | -4.52 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 413.94 Thousand | 349.96 Thousand | 1.36 Million | 3.08 Million | 570.91 Thousand | 618.93 Thousand |
| Change in working capital | -1.38 Million | -62.1 Thousand | 916.77 Thousand | 3.08 Million | 971.09 Thousand | 1.12 Million |
| Other non-cash items | 6.21 Million | 4.32 Million | 955.76 Thousand | 2.98 Million | 176.43 Thousand | 221.46 Thousand |
| Investing Cash Flow | - | - | 3.91 Million | - | 341.05 Thousand | -4.26 Million |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 3.91 Million | - | - | - |
| Financing Cash Flow | 7.98 Million | 4.71 Million | 5.02 Million | 9.27 Million | 125.94 Thousand | 4.11 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.98 Million | 4.71 Million | 5.75 Million | 5.75 Million | -4.11 Million | 4.11 Million |
| Other Financing Activities | -320.34 Thousand | -276.88 Thousand | 5.02 Million | 9.27 Million | 125.94 Thousand | 4.11 Million |
| Accounts receivables | -18.04 Thousand | -18.6 Thousand | -16.2 Thousand | 158.4 Thousand | 265.62 Thousand | -39.76 Thousand |
| Accounts payables | -609.8 Thousand | 237.01 Thousand | 407.88 Thousand | 471.89 Thousand | -320.65 Thousand | 419.83 Thousand |
| Inventory | - | - | 174.61 Thousand | - | -265.62 Thousand | 39.76 Thousand |
| Other working capital | -762.03 Thousand | -280.52 Thousand | 525.1 Thousand | 2.45 Million | 1.29 Million | 702.77 Thousand |
| Cash at beginning of period | 8.27 Million | 7.15 Million | 6.1 Million | 10.95 Million | 9.14 Million | 7.58 Million |
| Cash at end of period | 11.57 Million | 8.27 Million | 7.15 Million | 7.15 Million | 6.1 Million | 9.14 Million |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | 5434.00 | -9494.00 | 13.11 Thousand | -117.00 | -10.22 Thousand | 954.00 |
| Net cash flow / Change in cash | 3.3 Million | 1.12 Million | 1.04 Million | -3.8 Million | -3.04 Million | 1.55 Million |
| Free Cash Flow | -4.68 Million | -3.58 Million | -3.99 Million | -13.07 Million | -3.15 Million | -2.56 Million |
BESTAGRO
HADV
7607
0QLT
EBC
SSMS